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During inflammatory responses and wound healing, the conversion of soluble fibrinogen to fibrin, an
insoluble extracellular matrix, long has been assumed to create a scaffold for the migration of leukocytes and
fibroblasts. Previous studies concluded that fibrinogen is a necessary cofactor for mycobacterial trehalose
6,6-dimycolate-induced responses, because trehalose dimycolate-coated beads, to which fibrinogen was ad-
sorbed, were more inflammatory than those to which other plasma proteins were adsorbed. Herein, we
investigate roles for fibrin(ogen) in an in vivo model of mycobacterial granuloma formation and in infection
with Mycobacterium tuberculosis, the causative agent of tuberculosis. In wild-type mice, the subcutaneous
injection of trehalose dimycolate-coated polystyrene microspheres, suspended within Matrigel, elicited a
pyogranulomatous response during the course of 12 days. In fibrinogen-deficient mice, neutrophils were
recruited but a more suppurative lesion developed, with the marked degradation and disintegration of the
matrix. Compared to that in wild-type mice, the early formation of granulation tissue in fibrinogen-deficient
mice was edematous, hypocellular, and disorganized. These deficiencies were complemented by the addition of
exogenous fibrinogen. The absence of fibrinogen had no effect on cell recruitment or cytokine production in
response to trehalose dimycolate, nor was there a difference in lung histopathology or overall bacterial burden
in mice infected with Mycobacterium tuberculosis. In this model, fibrin(ogen) was not required for cell recruit-
ment, cytokine response, or response to infection, but it promoted granulation tissue formation and suppressed
leukocyte necrosis.
Fibrinogen is an approximately 340-kDa circulating glyco-
protein, a heterotrimer of A, B, and  chains (35). This
plasma protein is produced primarily in the liver by hepato-
cytes, with strong upregulation in response to proinflammatory
agents (16, 20, 35). The role of fibrinogen in the coagulation
cascade is well characterized, with the cleavage of fibrinogen by
thrombin to form fibrin, which then is covalently cross-linked
by activated Factor XIII to form the rigid, hemostatic fibrin
clot. Less well-known are the other functions of fibrin(ogen),
such as the mediation of platelet spreading, the promotion of
angiogenesis, and the stimulation of fibroblast proliferation (3,
7, 14, 22, 34). Fibrin(ogen) also is thought to provide a scaffold
along which leukocytes can migrate, and stimulated mono-
cytes and neutrophils express a high-affinity receptor for
fibrin(ogen), the integrin M2 (Mac-1) (1).
Mycobacterium tuberculosis is the leading cause of death due
to bacterial infection and currently is estimated to infect a third
of the world population (10, 12). In the context of tuberculosis,
fibrinogen has been shown to be upregulated during experi-
mental tuberculosis in mouse models and in natural human
infections, as occurs in other infectious diseases, resulting in a
hypercoagulable state (15, 30). Fibrinogen also has been iden-
tified as a cofactor for the pathological effects of mycobacterial
trehalose 6,6-dimycolate (TDM). Retzinger et al. demon-
strated that TDM adsorbed fibrinogen preferentially to the
exclusion of other plasma proteins, which increased the pyo-
granulomatous response to TDM (25). TDM is a predominant
mycobacterial cell wall component and an important virulence
factor for M. tuberculosis, in that it is granulomagenic, can
delay phagosome maturation, and is an active component of
complete Freund’s Adjuvant (2, 17, 18, 32). The presentation
of TDM as a higher-order polymer, as a monolayer either in
oil-water emulsions or on polystyrene particles, is required for
maximal bioactivity (13, 26). We use a bead-based delivery model
using 90-m polystyrene microspheres suspended within Matri-
gel, a commercially available mixture of extracellular matrix com-
ponents, to study the contributions of individual lipids to the
inflammatory response to mycobacteria (13, 27).
The development of a fibrinogen A chain-deficient mouse
(Fib knockout [KO]) has facilitated the direct study of the roles
of fibrinogen in inflammation (36). The use of this mouse
strain has revealed the roles of fibrinogen in the limitation of
Listeria monocytogenes growth in vivo (21), in the exacerbation
of crescentic glomerulonephritis (9), in the organization of
wound healing and wound stability (8), in tumor metastasis
(23), and in cell adhesion to biomaterials (6). On the other
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hand, a study of bleomycin-induced pulmonary fibrosis in Fib
KO mice showed that fibrosis developed independently of fi-
brin(ogen), and the absence of fibrin(ogen) increased the pres-
ence of neutrophils (40).
In this study, we use a subcutaneous granuloma model in Fib
KO mice to determine whether fibrinogen is necessary for the
inflammatory response to TDM. Our results show that while
fibrinogen is important for the organized formation of granu-
lation tissue, fibrinogen deficiency has no effect on leukocyte
recruitment to TDM-coated beads or proinflammatory cyto-
kine production by the recruited cells. Fib KO mice also show
no differences in pulmonary histopathology and only a tran-
sient difference in pulmonary bacterial burden in response to
intravenous infection with M. tuberculosis. However, Fib KO
mice show a suppurative response to TDM, resulting from the
exacerbation of neutrophil necrosis and matrix degradation,
whereas wild-type (WT) mice develop a granulomatous re-
sponse with less cell degeneration, necrosis, and matrix degra-
dation. These results show that fibrinogen is required neither
as a cofactor for initiating an inflammatory response to TDM
nor for controlling infection with M. tuberculosis, but rather
suppresses the cytotoxic effects of TDM on recruited neutro-
phils while promoting the formation of granulation tissue.
MATERIALS AND METHODS
Mice and cell culture. Fib KO mice (36) that were backcrossed seven gener-
ations to C57BL/6 mice were generously supplied by Jay Degen (Children’s
Hospital Research Foundation, Cincinnati, OH) and were bred at the Cornell
University Transgenic Mouse Core Facility. Tail snip genotyping was used to
identify the Fib KO, heterozygous (HET), and WT mice. Two- to 7-month-old
male and female mice were used for all in vivo experiments with the random-
ization of age and the sex of individuals within and between treatment groups.
Mice were weighed immediately after injection and every other day thereafter.
Animals were housed in a specific-pathogen-free animal facility. The Cornell
University Institutional Animal Care and Use Committee reviewed and ap-
proved all techniques used in these experiments. Murine bone marrow-derived
macrophages (BMM) were cultured as described previously (13).
Neutrophils were harvested from WT bone marrow using fluorescein isothio-
cyanate (FITC)-labeled, anti-mouse Gr-1/Ly-6G antibody (1A8; BD Biosciences,
San Jose, CA) and anti-FITC magnetic beads (Miltenyi Biotec, Gladbach, Ger-
many), followed by positive selection using an LS magnetic column in a Midi
MACS separation system (Miltenyi) by following the manufacturer’s protocol,
with slight modifications. Gr-1-positive macrophages were removed by adher-
ence to bacteriologic-grade 90-mm2 petri dishes (Kord-Valmark). Nonspecific
antibody binding was prevented by incubation with anti-mouse FcIII/IIR (5
g/ml; 2.4G2; Caltag Laboratories, Burlingame, CA) antibody in 0.5% bovine
serum albumin (BSA)–phosphate-buffered saline (PBS). Degassed 0.5% bovine
serum albumin (Sigma-Aldrich, St. Louis, MO) in PBS and sterile PBS were used
as running and rinsing buffers, respectively. All medium components were free of
endotoxin as determined by using the Limulus amoebocyte lysate assay (Cam-
brex, Charles City, IA).
Trehalose dimycolate. TDM was purified from Mycobacterium bovis Bacille
Calmette-Gue´rin (BCG) as described previously (13). Stocks were stored in
chloroform-methanol (2:1, vol/vol) under nitrogen gas at 20°C. M. tuberculosis
strain H37Rv TDM, purchased from Sigma-Aldrich, was diluted in n-hexane and
used for the in vitro neutrophil experiments.
Subcutaneous granuloma model. TDM was coated onto the surface of 90-m
polystyrene microspheres (Polysciences, Inc., Warrington, PA) as previously
described (27). Approximately 2  103 TDM-coated beads and 107 BMM of
the appropriate genotype were added per ml of an ice-cold solution of growth
factor-reduced Matrigel (90% in PBS; BD Biosciences). Three hundred micro-
liters of this mixture was injected subcutaneously in the scruff. Fibrinogen was
not detected in the Matrigel using an immunoblot technique with biotin-labeled
rabbit anti-mouse fibrinogen IgG (Molecular Innovations, Novi, MI). All gran-
uloma components and exogenous fibrinogen (Sigma-Aldrich) were tested rou-
tinely for endotoxin by the Limulus amoebocyte assay. Please note that since
2007, Polysciences has changed the formulation of its polystyrene particles,
altering the hydrophobicity and therefore the capacity of lipid coating. Similar
results have been achieved, however, using hydrophobic polystyrene particles
with a mean diameter of 80 m from Duke Scientific (Fremont, CA).
In vitro neutrophil experiments. TDM was dissolved in n-hexane by sonication
at 56°C. Twenty-four-well plates were coated with 5 g/well of TDM in n-hexane
or n-hexane only and dried overnight. Neutrophils were harvested as described
above and then added to TDM-treated, n-hexane-treated, or untreated wells at
1  105 cells per well, and then untreated cells were stimulated with 60 M
staurosporine (Sigma). Cells were treated in the presence or absence of 250 g
of murine fibrinogen (Sigma) per well in a final volume of 500 l. Neutrophils
were stimulated for 2 h at 37°C and 5% CO2, stained using allophycocyanin
(APC)-annexin V (Invitrogen) and propidium iodide (PI; 10 l/200 l; BD
Biosciences) by following manufacturer protocols, and then analyzed by flow
cytometry using a two-laser, four-color FACSCalibur and collecting at least
20,000 events. Antibodies against F4/80, CD3ε (145-2C11), CD19 (1D3), major
histocompatibility complex class II (MHC-II) (2G9), and Gr-1/Ly-6G (1A8) were
used as described below to determine neutrophil purity, which routinely was 70
to 80%. Contaminating cells were determined by flow cytometry to be Gr-1-
positive macrophages or bead-labeled cell fragments. Percentages of necrotic or
apoptotic neutrophils were determined first by gating upon FITC-positive cells,
followed by the analysis of the percentages of PI-positive and APC-annexin
V-positive cells.
Flow cytometry. Cells were recovered from matrices and processed as de-
scribed previously (27). Cells were incubated in fluorescent-activated cell sorting
(FACS) buffer containing fluorophore-conjugated antibodies from Caltag, BD
Pharmingen, or eBioscience (San Diego, CA) for 45 min. Antibodies were used
at 0.5 to 2 g/ml except for MHC-II (2G9), which was used at 5 g/ml. Other
antibodies used were Gr-1 (Ly-6G and Ly-6C, RB6-8C5), F4/80, CD3ε (145-
2C11), CD4 (CT-CD4), CD8 (53-6.7), CD19 (1D3), CD25 (PC61), CD45
(30-F11), pan-NK (DX5), and 	-TCR (GL3). Propidium iodide (10 l/200 l;
BD Biosciences) was added during the last 10 min of staining. Cells positive for
propidium iodide were gated out prior to collecting at least 10,000 events.
Leukocyte subsets were identified using the following cytometric parameters
on a two-laser, four-color FACSCalibur using CellQuest software (BD Bio-
sciences): neutrophils (side scatter [SSC]lo, Gr-1mid, or Gr-1hi, and MHC-II
F4/80), macrophages (Gr-1hi or Gr-1mid, and MHC-II
 F4/80
), eosinophils
(SSCmid Gr-1mid MHC-II F4/80mid), B cells (SSClo CD19
), CD4 T cells (SSClo
CD3
 CD4
), CD8 T cells (SSClo CD3
 CD8
), NK cells (SSClo pan NK
),
and 	 T cells (SSClo CD3
 	 TCR
). Cell numbers were determined for each
mouse in each group (n  4 or 5) by multiplying subset percentages by the
number of trypan blue-negative (viable) cells and normalizing to the weight of
the matrix from which the cells were retrieved.
ELISA. A portion (between 20 and 30 mg) of each harvested matrix was
cultured for 48 h in 500 l of Dulbecco’s modified essential medium (DMEM)
supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine, 1
mM sodium pyruvate, 100 U/ml penicillin, and 100 g/ml streptomycin. Super-
natants were collected, centrifuged to remove granuloma pieces, and stored at
80°C. Sandwich enzyme-linked immunosorbent assays (ELISAs) for tumor
necrosis factor- (TNF-), interleukin-6 (IL-6), IL-1, and IL-1 were per-
formed according to the manufacturer’s instructions (BD Biosciences).
Histology, immunohistochemistry, and immunofluorescence. A portion of
representative matrices was fixed immediately in 4% paraformaldehyde in PBS
for at least 24 h at 4°C, followed by transfer to 70% ethanol for at least 24 h
before submission for processing and sectioning by the Cornell University Col-
lege of Veterinary Medicine Histology Laboratory. Briefly, samples were em-
bedded in paraffin, sectioned at 4 m thickness, and stained with either hema-
toxylin and eosin (H&E) or Masson’s trichrome stain.
For caspase 3 detection, sections of 7-day-old TDM matrices from Fib KO
mice were incubated in 0.01 M citrate buffer, pH 6.0, in a microwave for two
10-min intervals at 800 W for antigen retrieval and then incubated for 2 h at 37°C
with rabbit anti-caspase 3 diluted 1:50 in PBS–1 casein. Biotinylated goat
anti-rabbit IgG H
L (Vector, Burlingame CA) was applied for 20 min at room
temperature, and slides were washed and incubated for 20 min with streptavidin
peroxidase (Zymed). AEC substrate was prepared as directed (Zymed kit) and
applied for 10 min. Slides were counterstained with Gill’s #2 hematoxylin and
mounted with Fluoromount G (both from Fisher Scientific, Fremont, CA).
Negative controls were included, substituting normal rabbit IgG (Vector) for the
primary antibody at the appropriate dilution equal to the final concentration
(g/ml) of primary antibody.
For immunofluorescence, sections of 7-day-old TDM matrices from Fib KO
mice were incubated in 1:50 dilutions of rabbit anti-human neutrophil elastase
(Fitzgerald Industries, Inc., Concord, MA) and mouse anti-human histone H1
(Acris Antibodies, Herford, Germany) or no primary antibody (negative control)
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overnight at 4°C, and then they were wetted with 1:1,000 Draq5 (Biostatus Ltd.,
Leicestershire, United Kingdom) immediately before being mounted in 9%
Mowiol 4-88 (Calbiochem, La Jolla, CA) in glycerol-Tris (1:4, vol/vol). Confocal
microscopy was performed using an AxioImager M1 microscope with a laser-
scanning microscope (LSM) 510 Meta confocal head with an EC PLAN Neofluor
(40 magnification, 1.3 numeric aperture) oil lens and Argon2 and HeNe lasers
(Carl Zeiss, Jena, Germany). Images were created using LSM 510 version 4.0
SP2 (Carl Zeiss MicroImaging GmbH). Images were processed using Adobe
Photoshop CS2 version 9.0.2 (Adobe Systems Inc., San Jose, CA). Autocontrast
tools were used on all of the images equally.
M. tuberculosis intravenous infection model. Two-month old, female Fib KO
and HET mice that were bred and maintained at the Trudeau Institute were used
for this experiment. M. tuberculosis strain H37Rv was grown as previously de-
scribed (29). Mice were injected intravenously via the tail vein at a final dose per
mouse of 1  105 CFU in saline. Mice were euthanized by CO2 narcosis, and
samples of lung, spleen, and liver then were individually homogenized in phys-
iological saline, and serial dilutions of the organ homogenate were plated on
nutrient 7H11 agar. Bacterial CFU were counted after 3 weeks of incubation at
37°C (29). A caudal lung lobe was perfused with 10% formalin–saline and fixed
for 1 week. Tissues were sent to Colorado Histoprep (Fort Collins, CO) for
routine paraffin embedding, serial sectioning, and staining using H&E and acid-
fast stains.
Statistical methods. All cell number calculations and cytokine measurements
were performed for individual mice, and the standard deviations (SD) from the
mean values (n  4 or 5) are presented. The statistical significance of differences
in the means between Fib KO and HET or WT mice was calculated using a
Student’s t test.
RESULTS
The response to BCG TDM in the subcutaneous compart-
ment of WT mice is pyogranulomatous, as opposed to suppu-
rative, in Fib KO mice. Previously, we developed a peritoneal
granuloma model to study the immunostimulatory activity of
different mycobacterial lipids (13). In preliminary experiments,
the injection of TDM matrices into the peritoneal cavity of Fib
KO mice resulted in fragmented pieces instead of the cohesive,
adherent matrices typically observed in our peritoneal granu-
loma model in WT mice (13 and data not shown). As the
increased exposed surface area of TDM-bearing matrix could
skew cell recruitment to the matrices, we opted for subcuta-
neous injection, wherein the matrices would be trapped as a
single mass in the subcutis.
By histologic examination, neutrophils were the primary leu-
kocyte recruited to the TDM beads in WT mice at 4 and 7 days,
with a shift toward increasing numbers of macrophages beginning
at 7 days and then a predominant macrophage response at 12
days, with occasional multinucleated giant cells (Fig. 1A to C). By
day 12, scattered foci within, but not limited to, the center of
the granulomas also contained eosinophilic ghost cells of re-
cruited neutrophils and macrophages, accompanied by the
degradation of the matrix, resembling early features of caseous
necrosis (Fig. 1D). These histologic features, an early neutro-
philic response developing into pyogranulomatous inflamma-
tion, are similar to those reported in our peritoneal granuloma
model (13), differing only in slower kinetics.
At 4 days, the beads in granulomas from Fib KO mice were
cuffed by moderate numbers of neutrophils, similarly to those in
the WT and HET mice (Fig. 1E). By day 7, however, severe
neutrophilic infiltration, with the degeneration and necrosis of
these leukocytes and nuclear streaming, was the predominant
feature in these matrices (Fig. 1F). These features were accom-
panied by the degradation of the Matrigel, characterized by the
contraction of the fractured pieces and hypereosinophilic stain-
ing. At day 12, the centers of some of these matrices were com-
pletely degraded and difficult to examine histologically, as much
of the liquefied material was washed away during processing (Fig.
1G). The increased liquefactive necrosis and destruction of the
matrix observed in Fib KO mice shows that fibrinogen suppresses
the cytotoxic effects of TDM or improves the survival of neutro-
phils in this subcutaneous model.
Fibrinogen is required for early organized granulation tis-
sue formation, and this deficiency can be complemented by
FIG. 1. Subcutaneous TDM matrices in WT mice are primarily neutrophilic at early time points but later become pyogranulomatous to granulo-
matous, while Fib KO matrices become progressively suppurative. WT and Fib KO mice (n 4 to 5 per time point) were injected subcutaneously in the
scruff with 300 l of TDM-coated 90-m-diameter microspheres suspended within Matrigel. Matrices were removed for analysis at days 4 (A and E),
7 (B and F), and 12 (C, D, and G). Representative samples were fixed, sectioned, and stained with H&E. Photomicrographs represent leukocytic
infiltrates in WT matrices (A to D) and in Fib KO matrices (E to G) typical for the depicted time point and are representative of three separate
experiments. Multinucleated giant cells (black arrows) are present in panel C. An area showing neutrophil degeneration and necrosis, as well as peripheral
eosinophilic ghost cells, as observed sporadically in 12-day-old TDM matrices from WT mice, is shown in panel D. The nuclear streaming of recruited
neutrophils (red arrows) is prominent in panel F. Original magnification, 1,000; bar  50 m.
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exogenous fibrinogen. In WT and HET mice, adherent, neovas-
cularized, pale yellow-white, translucent granulomas formed by
day 4 and developed a pale pink capsule by day 12 (Fig. 2A to C
and data not shown). Matrices injected into Fib KO mice also
were pale yellow and adherent to the surrounding tissues; how-
ever, at days 4 and 7, they generally were less vascularized than
those in WT mice (Fig. 2D and E). By day 12, however, the
matrices in Fib KO mice were covered by a pale pink, well-
vascularized capsule, grossly indistinguishable from those in the
WT or HET mice (Fig. 2F). In contrast to the WT and HET
mouse granulomas, the centers of KO granulomas occasionally
were white, liquefied, and oozed from the cut surface.
The histologic examination of the periphery of 4-day-old TDM
matrices in WT or Fib KO mice revealed loosely arranged but
parallel fibroblasts interspersed with neutrophils and macro-
phages (Fig. 3A and D). Well-developed granulation tissue was
present around the WT matrices by day 7, with the characteristic
parallel sheets of fibroblasts perpendicularly transected by imma-
ture blood vessels and interspersed with neutrophils, macro-
phages, and lymphocytes (Fig. 3B). By day 12, mature collagen
could be observed surrounding granulomas from these mice (Fig.
3C). Fib KO mice, on the other hand, did not develop well-
organized granulation tissue until day 12. Tissues surrounding
7-day-old matrices instead were edematous, hypocellular, and
poorly vascularized (Fig. 3E). This delay in the development of
granulation tissue in Fib KO mice at 7 days was complemented by
the addition of 500 g/ml of fibrinogen (Sigma) to the matrix
prior to injection (Fig. 3F). This dose of exogenous fibrinogen was
selected because it was the highest circulating concentration of
fibrinogen reported during experimental Candida peritonitis in
mice (28) and was the highest dose that could be added to the
matrix without diluting it significantly. These results show that
fibrinogen aids the early formation of granulation tissue but is not
required for capsule formation. Interestingly, the addition of fi-
brinogen did not reduce the recruited leukocyte death in Fib KO
matrices, as determined qualitatively by histopathology (data not
shown).
Fibrinogen protects neutrophils from TDM-induced necro-
sis in vitro. To determine the mechanism of cell death induced
by TDM in Fib KO mice, and because fibrinogen has been
reported previously to delay apoptosis (31), sections of 7-day-
old TDM matrices from Fib KO mice were stained for acti-
vated caspase 3, an effector caspase in the apoptosis pathway.
No staining above that of negative controls was observed (data
not shown), supporting the histopathologic evidence that apop-
tosis was not the mechanism by which recruited neutrophils
were dying. We therefore proceeded to study this mechanism
in vitro, using neutrophils harvested from murine bone mar-
row. Purified neutrophils were exposed to wells coated with
TDM, vehicle control (n-hexane), or 60 M staurosporine for
1, 2, 5, and 18 h in the presence or absence of 500 g/ml
fibrinogen, and then they were stained with APC-annexin V
and propidium iodide (PI) to determine the percentages of
cells that were apoptotic or necrotic, respectively, by flow cy-
tometry (Fig. 4 and data not shown). Although induced necro-
sis overall was low, statistical analysis showed significantly
greater necrosis (P 0.05) in response to TDM-coated wells at
2 h in the absence of fibrinogen (Fig. 4A). n-hexane-coated
wells did induce a background level of necrosis; however, it was
significantly less (P  0.05) than that induced by TDM (Fig.
4A). Fibrinogen also was significantly protective against necro-
sis in the n-hexane-treated neutrophils. TDM induced negligi-
ble neutrophil apoptosis at all of the time points studied (data
not shown). Fibrinogen also was protective in decreasing stau-
rosporine-induced apoptosis in neutrophils at 2 h (Fig. 4B), as
has been reported previously (31). Fibrinogen, therefore, plays
FIG. 2. Subcutaneous TDM matrices in Fib KO are grossly similar to those of the WT, with slight delays in neovascularization. TDM matrices
from WT (A to C) and Fib KO (D to F) mice were removed at days 4 (A and D), 7 (B and E), and 12 (C and F).
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a protective role in the preservation of TDM-stimulated neu-
trophils.
Neutrophil NETs are induced by TDM in the absence of
fibrinogen. The nuclear streaming that was a predominant
feature of the 7-day-old TDM matrices in Fib KO mice was
histologically similar to reports of neutrophil extracellular
traps (NETs), which are extruded neutrophil DNA and his-
tones complexed with neutrophil elastases that together have
antibacterial activity (4). Furthermore, M. tuberculosis recently
has been reported to induce NET formation in vitro (24). To
investigate the possibility that this lesion was consistent with
neutrophil NETs and that TDM could be a mycobacterial
factor inducing this response, we performed immunofluores-
cence on sections of Fib KO matrices using anti-neutrophil
elastase, anti-histone H1 antibodies, and the DNA stain Draq5
and examined them for colocalization by confocal microscopy.
Strong Draq5 and anti-histone H1 staining of the streaming
material confirmed the presence of DNA and histone H1 (Fig.
5A and E), while elastase was present both associated with this
DNA as well as in the cytoplasm of surrounding intact neutro-
phils (Fig. 5C). These results suggest that TDM is stimulating
the formation of NETs, particularly in the absence of fibrin-
ogen, and that fibrinogen plays a role in the regulation of
NETs.
Fibrinogen is not required for cell recruitment or cytokine
response to TDM, or for responses to infection with M. tuber-
culosis. The flow-cytometric analysis of cells harvested from
granulomas in three separate experiments showed no differ-
ences in the number of leukocytes in matrices from WT or
HET mice compared to those from Fib KO mice (data not
shown). Leukocytes that were analyzed included neutrophils,
macrophages, B cells, T cells (CD4
, CD8
, and 	TCR sub-
sets), and eosinophils that were identified by the combinations
of surface markers outlined in Materials and Methods (data
not shown). Matrices supplemented with exogenous fibrinogen
showed no differences in cell recruitment compared to that of
unsupplemented matrices from Fib KO mice (data not shown).
Levels of proinflammatory cytokines (TNF-, IL-6, IL-1, and
IL-1) were measured in supernatants of cells cultured from
explanted matrices. ELISA results showed no consistently sig-
nificant differences in the cytokines analyzed between the WT
and HET groups or the Fib KO group at any of the time points
(data not shown). These data suggest that the cell recruitment
and cytokine responses to TDM are not dependent upon the
presence of fibrinogen.
To test the overall importance of fibrinogen in the context of
M. tuberculosis infection, Fib KO and HET mice were infected
by tail vein injection, and tissues were taken at days 1, 8, 17, 30,
and 60 for histopathology and bacterial enumeration. No his-
topathologic differences were observed in the lung, liver, or
spleen at any of the time points (data not shown). A single
statistically significant (P  0.05) difference in the load of
viable bacteria was observed at 17 days in the lung, with lower
numbers in the Fib KO mice (3.57 log10 CFU  0.05 for Fib
KO mice and 3.89 log10 CFU  0.19 for HET mice) (Table 1).
A low-dose (100 CFU) aerosol infection experiment also was
performed as described in Mogues et al., and no significant
differences in CFU or histopathology were observed at 50 days
postinfection (R. North, personal communication) (19). These
results suggest that fibrinogen is required for neither immune
FIG. 3. Granulation tissue and capsule formation in KO matrices is delayed and impaired but can be complemented by the addition of
exogenous fibrinogen. Sections of TDM matrices were stained using Masson’s trichrome stain to show the deposition of collagen (blue) during
capsule formation. The capsule surrounding WT (A) and Fib KO (D) matrices at 4 days is loosely organized and histologically similar.
Well-developed granulation tissue surrounds 7-day-old WT matrices (B), and by 12 days (C), the capsule is composed primarily of collagen. (E) In
Fib KO matrices, however, the granulation tissue response at 7 days is disorganized, edematous, and hypocellular, similar to the appearance at 4
days. (F) The addition of 500 g/ml fibrinogen to the KO matrices allows well-organized granulation tissue to surround the matrix at 7 days.
Asterisks indicate the interface between Matrigel and capsule. Original magnification, 200.
1008 SAKAMOTO ET AL. INFECT. IMMUN.
responses to TDM nor the overall control of infection with M.
tuberculosis.
DISCUSSION
The tuberculosis granuloma represents a complex dance be-
tween the bacillus and the host. Mycobacterial components
stimulate a robust but organized leukocyte response that serves
to contain the mycobacteria while not eradicating them com-
pletely, allowing the host and parasite to coexist for decades.
However, some granulomas in some individuals progress to
necrosis and caseation, facilitating the release of bacteria into
the airways and, therefore, transmission. The factors that de-
termine whether this progression occurs currently are un-
known. TDM, a strong proinflammatory mycobacterial cell
wall component, is postulated to play a dominant role in driv-
ing granuloma development and breakdown.
Fibrin(ogen) is a critical component of the acute inflamma-
tory response and forms a scaffold along which leukocytes,
endothelial cells, and fibroblasts could migrate in order to
begin the repair process. Fibrin(ogen) has been described as a
necessary cofactor for the toxic and proinflammatory activities
of TDM (25). This would have predicted that Fib KO mice
would mount a lesser inflammatory response to TDM. Inter-
estingly, Fib KO mice showed exacerbated immunopathology,
no reduction in either cell recruitment or proinflammatory
cytokine response to TDM-coated particles, and no clear phe-
notype in intravenous or aerosol infection with M. tuberculosis.
The response in Fib KO mice to TDM was more suppurative,
which, while not appreciated by FACS analysis, clearly could
be observed by histopathology. This discrepancy likely is due to
the exclusion of dead (propidium iodide-positive) cells and
debris in the FACS analysis. Slight kinetic differences were
observed in the granulation tissue and neovascularization re-
sponse to these matrices, processes that are well documented
in the literature to rely on fibrinogen (5, 8, 33). This disorga-
FIG. 4. Fibrinogen suppresses TDM-induced neutrophil necrosis
in vitro. Bone marrow-derived neutrophils were purified and stimu-
lated by TDM, vehicle control (n-hexane), or 60 M staurosporine for
2 h in the presence or absence of 500 g/ml fibrinogen and then
stained using propidium iodide (PI) and annexin V to determine the
percentage of the neutrophil population that is necrotic or apoptotic,
respectively, by flow cytometry. (A) TDM induces a significantly higher
percentage of PI-positive cells above that of the vehicle (n-hexane)
control, and this percentage is significantly reduced in the presence of
fibrinogen. (B) Staurosporine-induced neutrophil apoptosis, but not
necrosis, also is significantly reduced in the presence of fibrinogen.
Data from triplicate samples from a representative experiment are
shown as means  standard deviations, and asterisks indicate statisti-
cally significant differences (P  0.05).
FIG. 5. TDM induces NETs in the absence of fibrinogen. Sections
of 7-day-old TDM matrices from Fib KO mice were labeled using
rabbit anti-human neutrophil elastase and mouse anti-human histone
H1, followed by Alexa Fluor 555 goat anti-rabbit and Alexa Fluor 488
goat anti-mouse antibodies and the DNA stain Draq5, and then ex-
amined by confocal immunofluorescence microscopy. (A) Histone H1
is observed along the surface of the streaming DNA. (C) Neutrophil
elastase is observed within intact neutrophils (arrows) as well as along
the streaming neutrophil DNA. (E) Draq5 staining indicates that this
streaming material is composed of DNA. (B and D) Negative control
sections were stained only with secondary antibody for H1 and elas-
tase, respectively.
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nization of granulation tissue in Fib KO mice may have al-
lowed greater access to the matrices by neutrophils. These
results suggest that perhaps fibrin(ogen) plays a more impor-
tant regulatory role in the response to mycobacterial TDM
than previously postulated, at least in the subcutis.
While our results show that fibrin(ogen) is not a required
cofactor for TDM-induced inflammation or control of infec-
tion, we show that fibrin(ogen) plays a vital role in the initial
containment of inflammation, as the TDM matrices splintered
after intraperitoneal injection in Fib KO mice and subcutane-
ous matrices showed delayed capsule formation (Fig. 3E and
data not shown). A factor to consider is that fibrin usually is
present in greater amounts within the peritoneal cavity after
infection or surgery due to decreased fibrinolytic activity, sug-
gesting that there are differences in the role of fibrin(ogen)
between different body compartments (37). It is interesting,
however, that leukocytes, endothelial cells, and fibroblasts,
while perhaps delayed to a degree, were not impaired in their
migration toward the TDM-coated microspheres without fibrin
present to provide a scaffold or chemokine/growth factor gra-
dient. It is possible that the Matrigel fulfilled this role in our
model, since while growth factor reduced, this embryonic stem
cell mouse sarcoma-derived substance contains known growth
factors, such as transforming growth factor-, and potentially
unknown components that may affect leukocyte recruitment
and survival, even though fibrinogen was not detected by im-
munoblotting. It also is possible that no extracellular matrix
components actually are needed in the Matrigel model; how-
ever, the current study cannot distinguish between these two
possibilities. In an attempt to address this problem, we added
exogenous fibrinogen to the TDM bead-containing matrix in
Fib KO mice. While the added fibrinogen correlated with a
return to the histological appearance of the capsule of the WT
matrices, confirming that fibrinogen supports the generation of
granulation tissue, it did not reduce recruited leukocyte death.
This method of complementing fibrinogen may not allow for its
proper availability for regulating the cytotoxic effects of TDM;
therefore, other in vivo scaffold systems such as poly(lactic-co-
glycolic) acid currently are being investigated in our laboratory
as a replacement for Matrigel. Invariably, what occurs during
in vivo infection is the most relevant data, and the result that
no phenotype is observed with both intravenous and aerosol
infection clearly supports that fibrinogen is not required for
immune responses to M. tuberculosis.
The leukocyte death that was a predominant feature of the
TDM matrices in Fib KO mice also may be the result of
reduced neovascularization. In this model, we could only qual-
itatively assess neovascularization, at necropsy and by histopa-
thology. Whereas 4- and 7-day-old matrices from Fib KO mice
seemed less vascularized grossly and histologically, by 12 days
no differences were observed between Fib KO and WT mice. It
is possible that this delay resulted in a reduced oxygen supply
to the center of the Fib KO matrices, causing necrosis second-
ary to hypoxia. In this case, the cytotoxic effect of TDM in the
absence of fibrinogen would be an indirect result of the delay
in neovascularization. A direct cytotoxic effect of TDM on
neutrophils, however, was shown in vitro (Fig. 4A). Further-
more, necrosis was not limited to the centers of the Fib KO
matrices but occasionally was observed surrounding TDM
beads at the periphery and also within WT matrices that were
well vascularized (Fig. 1D). Matrix degradation in the presence
of fibrinogen, as studied by in situ zymography, is due primarily
to matrix metalloproteinase 9 activity (K. Sakamoto, unpub-
lished results), and certainly neutrophil elastases may play a
role (Fig. 5); however, the mechanism of TDM-induced necro-
sis in the absence of fibrinogen needs further study.
Fibrinogen also may enhance the survival of recruited leu-
kocytes. Studies have shown that the binding of fibrinogen to
the integrin receptor M2/Mac-1 is critical for leukocyte func-
tion and regulates apoptosis in neutrophils (11, 38, 39). The
immunohistochemical staining of TDM matrices from both Fib
KO and WT mice, however, showed no activated caspase 3
staining, suggesting that leukocyte death in this case is primar-
ily by necrosis. Furthermore, bone marrow-derived neutrophils
stimulated with TDM in vitro showed a significantly higher
percentage of necrotic, but not apoptotic, cells in the absence
of fibrinogen (Fig. 4A). The histopathologic appearance of
dead neutrophils, along with the colocalization of neutrophil
histone H1, elastase, and DNA in these lesions, suggests that
TDM induces the formation of NETs in the absence of fibrin-
ogen (Fig. 1F and 5). Why greater leukocyte necrosis and NET
formation are observed in the absence of fibrinogen, however,
still is unclear. The study of TDM effects in mice with a tar-
geted deletion of the M2 binding motif within the fibrinogen
 chain may help to answer this question (11).
There are many events that occur in the tuberculosis gran-
uloma, and it is thought that not all are productive for the
containment or resolution of the infection. TDM is thought to
be a virulence factor because it reproduces several symptoms
of tuberculosis, namely, the excessive production of proinflam-
matory cytokines, cachexia, weight loss, and local necrosis (and
in some cases, caseous necrosis in mice) (17). In other reports,
we have demonstrated that although TDM triggers granuloma-
genic events, they often are excessive and unregulated com-
pared to the responses elicited by intact bacilli (13). Notably,
TDM elicits the excessive production of TNF- and recruits
large numbers of granulocytes, events associated with destruc-
tive tissue remodeling and toxicity in mice. The mechanisms
that drive these pathological events are unknown. Our current
findings indicate that fibrinogen regulates the response to
TDM in at least two ways: (i) fibrinogen contributes to limiting
TABLE 1. Absence of fibrinogen results in only a slight, transient
decrease in liver bacterial burden on day 17 of infection with M.
tuberculosis
Day Group
Log10 CFU per organa
Lung Spleen Liver
1 HET 1.58  0.27
8 HET 5.84  0.17 5.00  0.14 2.53  0.27
KO 5.70  0.05 4.96  0.19 2.48  0.33
17 HET 6.03  0.21 4.87  0.35 3.89  0.19
KO 5.93  0.14 4.99  0.16 3.57  0.05b
30 HET 5.49  0.12 4.20  0.17 4.28  0.43
KO 5.41  0.06 4.3  0.00 4.46  0.73
60 HET 5.76  0.08 4.30  0.35 4.68  0.19
KO 5.71  0.18 4.32  0.28 4.83  0.02
a Values are means  standard deviations (4 mice per group) for M. tubercu-
losis CFU in organ homogenates from Fib HET or KO mice.
b Significantly different (P  0.05) from the value for HET mice at 17 days of
infection as calculated by Student’s t test.
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leukocyte necrosis, and (ii) fibrinogen contributes to the for-
mation of granulation tissue that may serve to contain the
response.
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